This hyper-growth is driven by the potential for NK cells to provide a safer alternative to CAR-T therapies, with a lower risk of cytokine release syndrome (CRS) and graft-versus-host disease (GvHD).NK cells are a type of cytotoxic lymphocyte critical to the innate immune system, capable of recognizing and killing virally infected or cancerous cells without prior sensitization. As res... https://www.databridgemarketresearch.com/nucleus/global-natural-killer-(nk)-cell-therapeutics-market